• All Share : 48530.47
    UNCHANGED0.00%
    Top 40 : 3936.07
    UNCHANGED0.00%
    Financial 15 : 14140.50
    UNCHANGED0.00%
    Industrial 25 : 58200.02
    UNCHANGED0.00%

  • ZAR/USD : 11.0335
    UP 0.02%
    ZAR/GBP : 17.7937
    UP 0.05%
    ZAR/EUR : 14.0530
    UP 0.15%
    ZAR/JPY : 0.1032
    UP 0.08%
    ZAR/AUD : 9.7041
    UP 0.30%

  • Gold : 1248.0000
    DOWN -0.03%
    Platinum : 1277.0000
    UP 0.16%
    Silver : 17.4550
    DOWN -0.30%
    Palladium : 776.2500
    UP 0.68%
    Brent Crude Oil : 86.310
    UP 0.10%

  • All data is delayed by 15 min. Data supplied by I-Net Bridge
    Hover cursor over this ticker to pause.

Send Mail

Melanoma drug nearly doubles survival time: study

A new drug to treat advanced skin cancer, or metastatic melanoma, has been shown to nearly double average survival time in a study of more than 130 patients, researchers said.

AFP Relaxnews

 24 February, 2012 10:45
* Required